Poly(vinylpyrrolidone)

Awasthi, R; Manchanda, S; Das, P; Velu, V; Malipeddi, H; Pabreja, K; Pinto, TDJA; Gupta, G; Dua, K

Poly(vinylpyrrolidone)

Awasthi, R Manchanda, S Das, P Velu, V Malipeddi, H Pabreja, K Pinto, TDJA Gupta, G Dua, K

Permalink

Publication Type:: Chapter
Citation:: Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol, 2018, pp. 255 - 272
Issue Date:: 2018-01-27

Closed Access

	Filename	Description	Size
	Engineering_of_Biomaterials_for_Drug_Delivery_Syst..._----_(9_Poly(vinylpyrrolidone)).pdf	Published version	558 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Awasthi, R	en_US
dc.contributor.author	Manchanda, S	en_US
dc.contributor.author	Das, P	en_US
dc.contributor.author	Velu, V	en_US
dc.contributor.author	Malipeddi, H	en_US
dc.contributor.author	Pabreja, K	en_US
dc.contributor.author	Pinto, TDJA	en_US
dc.contributor.author	Gupta, G	en_US
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159	en_US
dc.date.issued	2018-01-27	en_US
dc.identifier.citation	Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol, 2018, pp. 255 - 272	en_US
dc.identifier.isbn	9780081017500	en_US
dc.identifier.uri	http://hdl.handle.net/10453/128355
dc.description.abstract	© 2018 Elsevier Ltd. All rights reserved. Poly(vinylpyrrolidone) (PVP) is one of the most commonly employed synthetic hydrophilic (nonionic) excipient in pharmaceutical formulations. Professor Walter Rappe and his team first developed this excipient during the 1930s and it is now gaining popularity due to its properties such as being nonantigenic, and hence avoiding the danger of infectious diseases inherent in blood. This chapter covers the basic introduction, physicochemical properties, synthesis, and the applications of PVP for its applications in pharmaceutical preparations such as solid, liquid, and semi-solid dosage forms including the PVP-based patented pharmaceutical products.	en_US
dc.relation.ispartof	Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol	en_US
dc.relation.isbasedon	10.1016/B978-0-08-101750-0.00009-X	en_US
dc.title	Poly(vinylpyrrolidone)	en_US
dc.type	Chapter
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.publication-status	Published	en_US

Abstract:

© 2018 Elsevier Ltd. All rights reserved. Poly(vinylpyrrolidone) (PVP) is one of the most commonly employed synthetic hydrophilic (nonionic) excipient in pharmaceutical formulations. Professor Walter Rappe and his team first developed this excipient during the 1930s and it is now gaining popularity due to its properties such as being nonantigenic, and hence avoiding the danger of infectious diseases inherent in blood. This chapter covers the basic introduction, physicochemical properties, synthesis, and the applications of PVP for its applications in pharmaceutical preparations such as solid, liquid, and semi-solid dosage forms including the PVP-based patented pharmaceutical products.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/128355